Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis.

摘要: Department of Genetics and Developmental Biology, University Connecticut Health Center, Farmington, CT, USA Prenatal Diagnosis Unit, Institute Gynecology, Obstetrics Neonatology, Hospital Clinic, Maternitat Campus, Barcelona Medical School, Catalonia, Spain Chemical Pathology, The Chinese Hong Kong, Prince Wales Hospital, Kong Columbia New York, NY, Pennsylvania, Philadelphia, PA, Human Genetics, Radboud Nijmegen Centre, Nijmegen, Netherlands Albert Einstein College Medicine, Calgary, AB, Canada Assaf Harofe Sackler Faculty Tel Aviv University, Aviv, Israel Stanford School Stanford, CA, Washington in St Louis, MO, Laboratory for Infectious Diseases Perinatal Screening, National Public the Environment (RIVM), Bilthoven, Screening Clinical Biochemistry Department, Barking Havering & Redbridge Hospitals, King George Goodmayes, UK Program, North York General Toronto, ON, Mathematics Statistics, Plymouth, Genetic Institute, Sourasky *Correspondence to: Peter Benn. E-mail: benn@nso1.uchc.edu This Statement replaces January 2011 (Prenatal 2011;31:519–522) Rapid Response 2012;32:1–2).